4 posts in this category
Confused about how Medicare may cover GLP-1 weight loss drugs after the TrumpRx deal Learn who may qualify, expected costs, and key dates until 2027.
A clear look at the next wave of GLP-1 drugs in 2026 — launches, filings, access changes and what patients and payers should know.
From access issues to mindset and side effects, here are the most common mistakes people make on GLP-1 therapy—and how to fix them.
Trump’s plan could cut GLP-1 drug prices — like Ozempic® and Wegovy® — to $150/month. Here’s what’s real, what’s pending, and who it helps.
